Circadian rhythms and medical diseases: Does it matter when drugs are taken?

European Journal of Internal Medicine

Volumn 24, Issue 8, 2013, Pages 698-706

  De Giorgi, Alfredo ^a   Mallozzi Menegatti, Alessandra ^a   Fabbian, Fabio ^a   Portaluppi, Francesco ^a   Manfredini, Roberto ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Chronobiology; Chronotherapy; Circadian rhythm; Disease; Internal medicine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTACID AGENT; ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISRADIPINE; NEBIVOLOL; NIFEDIPINE; NISOLDIPINE; OLMESARTAN; PERINDOPRIL; PROPRANOLOL; RAMIPRIL; RANITIDINE; SIMVASTATIN; TORASEMIDE; UNINDEXED DRUG; VALSARTAN; ZOFENOPRIL;

ARTHRITIS; ASTHMA; BIOLOGICAL RHYTHM; CHRONOBIOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; EVENING DOSAGE; HUMAN; MEDICAL SUBJECT HEADINGS; MEDLINE; MORNING DOSAGE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLOW RELEASE FORMULATION;

CHRONOBIOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; DISEASE; INTERNAL MEDICINE;

ANALGESICS; ANTI-ASTHMATIC AGENTS; ANTI-ULCER AGENTS; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; DRUG CHRONOTHERAPY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 84889668363     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.03.019     Document Type: Review

References (99)

1. I. Edery Circadian rhythms in a nutshell Physiol Genomics 3 2000 59 74
2. D.J. Durgan, and M.E. Young The cardiomyocyte circadian clock. Emerging roles in health and disease Circ Res 106 2010 647 658
3. M.H. Smolensky, R.A. Siegel, E. Haus, R. Hermida, and F. Portaluppi Biological rhythms, drug delivery, and chronotherapeutics J. Siepmann, R.A. Siegel, M.J. Rathbone, Fundamentals and applications of controlled release drug delivery 2012 Springer US 359 443
4. F. Portaluppi, R. Manfredini, and C. Fersini From a static to a dynamic concept of risk: the circadian epidemiology of cardiovascular events Chronobiol Int 16 1999 33 49
5. R.C. Hermida, D.E. Ayala, and F. Portaluppi Circadian variation of blood pressure: the basis for the chronotherapy of hypertension Adv Drug Deliv Rev 59 2007 904 922
6. R.C. Hermida, D.E. Ayala, A. Mojón, and J.R. Fernández Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study Chronobiol Int 27 2010 1629 1651
7. R. Manfredini, M. Gallerani, F. Portaluppi, and C. Fersini Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms Ann N Y Acad Sci 783 1996 141 158
8. R. Manfredini, B. Boari, R. Salmi, F. Fabbian, M. Pala, and R. Tiseo 24-hour pattern in the occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease Chronobiol Int 30 2013 6 16
9. R.C. Hermida, and D.E. Ayala Chronotherapy with the angiotensin- converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing Hypertension 54 2009 40 46
10. K. Witte, K. Weisser, M. Neubeck, E. Mutschler, K. Lehmann, and R. Hopf Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration Clin Pharmacol Ther 54 1993 177 186
11. H. Bǎlan, E. Popescu, and G. Angelescu Comparing different treatment schedules of Zomen (Zofenopril) Rom J Intern Med 49 2011 75 84
12. P. Palatini, L. Mos, M. Motolese, P. Mormino, M. Del Torre, and L. Varotto Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring Int J Clin Pharmacol Ther Toxicol 3 1993 295 300
13. T. Morgan, A. Anderson, and E. Jones The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night J Hypertens 15 1997 205 211
14. R.C. Hermida, D.E. Ayala, L. Chayan, A. Mojon, and J.R. Fernandez Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients Chronobiol Int 26 2009 61 79
15. R.C. Hermida, C. Calco, D.E. Ayala, M.J. Dominquez, M. Covelo, and J.R. Fernandez Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects Hypertension 42 2003 283 290
16. R.C. Hermida, D.E. Ayala, J.R. Fernández, and C. Calvo Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension Hypertension 50 2007 715 722
17. R.C. Hermida, C. Calvo, D.E. Ayala, J.E. López, M. Rodríguez, and L. Chayán Dose and administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects Chronobiol Int 24 2007 471 493
18. R.C. Hermida, D.E. Ayala, A. Mojón, and J.R. Fernández Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing Am J Hypertens 21 2008 948 954
19. G. Nold, G. Strobel, and B. Lemmer Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients Blood Press Monit 3 1998 17 25
20. T. Mengden, B. Binswanger, T. Spühler, B. Weisser, and W. Vetter The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening J Hypertens 11 1993 1403 1411
21. F. Portaluppi, L. Vergnani, R. Manfredini, E.C. degli Uberti, and C. Fersini Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure Am J Hypertens 8 1995 719 726
22. W.B. White, G.A. Mansoor, T.G. Pickering, D.G. Vidt, H.G. Hutchinson, and R.B. Johnson Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate Am J Hypertens 12 1999 806 814
23. R.C. Hermida, D.E. Ayala, A. Mojón, L. Chayán, M.J. Domínguez, and M.J. Fontao Comparison of the effect on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension Chronobiol Int 25 2008 950 970
24. M.C. Acelajado, R. Pisoni, T. Dudenbostel, S. Oparil, D.A. Calhoun, and S.P. Glasser Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients J Am Soc Hypertens 6 2012 66 72
25. J.M. Neutel, and K. Rotenberg Comparison of a chronotherapeutically administered beta blocker vs. A traditionally administered beta blocker in patients with hypertension J Clin Hypertens (Greenwich) 7 2005 395 400
26. T.G. Pickering, M. Levenstein, P. Walmsley Hypertension and Lipid Trial Study Group Night-time dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT study Am J Hypertens 7 1994 844 847
27. A. Hoshino, T. Nakamura, and H. Matsubara The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy Clin Exp Hypertens 32 2010 416 422
28. R.C. Hermida, D.E. Ayala, M.J. Fontao, A. Mojón, and J.R. Fernández Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing Chronobiol Int 27 2010 1287 1303
29. J. Zeng, M. Jia, H. Ran, H. Tang, Y. Zhang, and J. Zhang Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing - a multicenter, open-label randomized study Hypertens Res 34 2011 767 772
30. R.C. Hermida, D.E. Ayala, A. Mojón, M.J. Fontao, and J.R. Fernández Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing Chronobiol Int 28 2011 601 610
31. R. Asmar, P. Gosse, S. Queré, and A. Achouba Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine Blood Press Monit 16 2011 80 86
32. M. Middeke, M. Klüglich, and H. Holzgreve Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing Chronobiol Int 8 1991 506 510
33. R.C. Hermida, D.E. Ayala, A. Mojón, and J.R. Fernández Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD J Am Soc Nephrol 22 2011 2313 2321
34. A. Moyá, J.J. Crespo, D.E. Ayala, M.T. Ríos, L. Pousa, and P.A. Callejas Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes Chronobiol Int 30 2013 116 131
35. Y. Saito, S. Yoshida, N. Nakaya, Y. Hata, and Y. Goto Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study Arterioscler Thromb 11 1991 816 826
36. A. Wallace, D. Chinn, and G. Rubin Taking simvastatin in the morning compared with in the evening: randomised controlled trial BMJ 327 2003 788
37. H. Scharnagl, M. Vogel, C. Abletshauser, F. Freisinger, T. Stojakovic, and W. März Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration Cardiology 106 2006 241 248
38. G. Fauler, C. Abletshauser, W. Erwa, R. Löser, K. Witschital, and W. März Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics Int J Clin Pharmacol Ther 45 2007 328 334
39. D.D. Cilla Jr., D.M. Gibson, L.R. Whitfield, and A.J. Sedman Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening J Clin Pharmacol 36 1996 604 609
40. R. Plakogiannis, H. Cohen, and D. Taft Effects of morning versus evening administration of atorvastatin in patients with hyperlipidemia Am J Health Syst Pharm 62 2005 2491 2494
41. P.D. Martin, P.D. Mitchell, and D.W. Schneck Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers Br J Clin Pharmacol 54 2002 472 477
42. T. Roth, G.R. Richardson, J.P. Sullivan, R.M. Lee, L. Merlotti, and T. Rohers Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance Clin Cardiol 15 1992 426 432
43. R. Plakogiannis, and H. Cohen Optimal low-density cholesterol lowering - morning versus evening statin administration Ann Pharmacother 41 2007 106 110
44. H.S. Yoon, S.H. Kim, J.K. Kim, S.H. Ko, J.E. Ko, and S.J. Park Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia Ann Pharmacother 45 2011 841 849
45. R. Manfredini, B. Boari, S. Bressan, M. Gallerani, R. Salmi, and F. Portaluppi Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls Am J Emerg Med 22 2004 555 559
46. I. Casetta, E. Granieri, E. Fallica, O. la Cecilia, E. Paolino, and R. Manfredini Patient demographic and clinical features and circadian variation in onset of ischemic stroke Arch Neurol 59 2002 48 53
47. I. Casetta, E. Granieri, F. Portaluppi, and R. Manfredini Circadian variability in hemorrhagic stroke JAMA 287 2002 1266 1267
48. E. Haus, M. Cusulos, L. Sackett-Lundeen, and J. Swoyer Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects Chronobiol Int 7 1990 203 216
49. S. Kapiotis, B. Jilma, P. Quehenberger, K. Ruzicka, S. Handler, and W. Speiser Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1 + 2, and plasmin-plasmin inhibitor complex Circulation 96 1997 19 21
50. H.A. Decousus, M. Croze, F.A. Levi, J.G. Jaubert, B.M. Perpoint, and J.F. De Bonadona Circadian changes in anticoagulant effect of heparin infused at a constant rate Br Med J (Clin Res Ed) 290 1985 341 344
51. P. Mismetti, B. Perpoint, S. Laporte-Simitsidis, B. Tardy-Poncet, J. Reynaud, and Y. Cherrah Chronopharmacology of fractionated heparin (nadroparin) administrated by subcutaneous route at prophylactic doses in healthy volunteers Therapie 47 1992 557 560
52. P. Mismetti, J. Reynaud, B. Tardy-Ponce, S. Laporte-Simitsidis, M. Scully, and C. Goodwyn Chrono-pahramacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/Kg of Dalteparin) in ten healthy volunteers Thromb Haemost 74 1995 660 666
53. B.E. Bleske, L.S. Welage, E.W. Warren, M.B. Brown, and M.J. Shea Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients Pharmacotherapy 15 1995 709 712
54. C.H. Ho, M.W. Linc, J.Y. Youa, C.C. Chena, and T.J. Yub Variations of prothrombin time and international normalized ratio in patients treated with warfarin Thromb Res 107 2002 277 280
55. I. Kriszbacher, M. Koppán, and J. Bódis Aspirin for stroke prevention taken in the evening? Stroke 35 2004 2760 2761
56. C.M. Campbell, S.C. Bounds, M.B. Simango, K.R. Witmer, J.N. Campbell, and R.R. Edwards Self-reported sleep duration associated with distraction analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin nociceptive model Eur J Pain 15 2011 561 567
57. I.C. Kowanko, R. Pownall, M.S. Knapp, A.J. Swannell, and P.G. Mahoney Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day Br J Clin Pharmacol 11 1981 477 484
58. N. Bellamy, R.B. Sothern, J. Campbell, and W.W. Buchanan Rhythmic variation in pain, stiffness, and manual dexterity in hand osteoarthritis Ann Rheum Dis 61 2002 1075 1080
59. G. Labrecque, and M. Vanier Rhythms, pain and pain management P. Redfern, Chronotherapeutics 2003 Pharmaceutical Press London. 212 233
60. D.L. Pikula, E.F. Harris, D.M. Desiderio, G.H. Fridland, and J.L. Lovelace Methionine enkephalin-like, substance P-like, and beta-endorphin-like immunoreactivity in human parotid saliva Arch Oral Biol 37 1992 705 709
61. S. Barni, P. Lissoni, F. Rovelli, S. Crispino, F. Paolorossi, and D. Esposti Alteration of opioid peptide circadian rhythm in cancer patients Tumori 74 1988 357 360
62. L. Pöllmann Circadian variation of potency of placebo as analgesic Funct Neurol 2 1987 99 103
63. J. Malan, J. Moncrieff, and E. Bosch Chronopharmacokinetics of paracetamol in normal subjects Br J Clin Pharmacol 19 1985 843 845
64. J.A. Kolawole, P.D. Chuhwak, and S.O. Okeniyi Chronopharmacokinetics of acetaminophen in healthy human volunteers Eur J Drug Metab Pharmacokinet 27 2002 199 202
65. M. Ollagnier, H. Decousus, Y. Cherrah, F. Levi, M. Mechkouri, and P. Queneau Circadian changes in the pharmacokinetics of oral ketoprofen Clin Pharmacokinet 12 1987 367 378
66. B. Perpoint, P. Mismetti, S. Simitsidis, J. Hocquart, C. Rambaud, and A. Buchmuller Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis Chronobiol Int 11 1994 119 125
67. J. Clench, A. Reinberg, Z. Dziewanowska, J. Ghata, and M. Smolensky Circadian changes in the bioavailability and effects of indomethacin in healthy subjects Eur J Clin Pharmacol 20 1981 359 369
68. F. Levi, C. Le Louarn, and A. Reinberg Timing optimizes sustained-release indomethacin treatment of osteoarthritis Clin Pharmacol Ther 37 1985 77 84
69. J.G. Moore, and R.H. Goo Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man Chronobiol Int 4 1987 111 116
70. F. Buttgereit, G. Doering, A. Schaeffler, S. Witte, S. Sierakowski, and E. Gromnica-Ihle Efficacy of modified release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial Lancet 371 2008 205 214
71. D.A. Graves, R.L. Batenhorst, R.L. Bennett, J.G. Wettstein, W.O. Griffen, and B.D. Wright Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity Clin Pharm 2 1983 49 53
72. E. Bruera, K. Macmillan, N. Kuehn, and M.J. Miller Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain: a preliminary report Pain 49 1992 311 314
73. P. Klepstad, E. Skogvoll, S. Kaasa, and P.C. Borchgrevink Circadian distribution of oral opioid consumption in cancer patients Methods Find Exp Clin Pharmacol 22 2000 753 755
74. M. Gallerani, R. Manfredini, D. Dal Monte, G. Calò, V. Brunaldi, and M. Simonato Circadian differences in the individual sensitivity to opiate overdose Crit Care Med 29 2001 96 101
75. G.K. Gourlay, J.L. Plummer, and D.A. Cherry Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution Pain 6 1995 375 381
76. M. Boom, J. Grefkens, E. van Dorp, E. Olofsen, G. Lourenssen, and L. Aarts Opioid chronopharmacology: influence of timing of infusion on fentanyl's analgesic efficacy in healthy human volunteers J Pain Res 3 2010 183 190
77. T. Hummel, H.G. Kraetsch, J. Lötsch, M. Hepper, J. Liefhold, and G. Kobal Analgesic effects of dihydrocodeine and tramadol when administered either in the morning or evening Chronobiol Int 12 1995 62 72
78. H.S. Merki, C.J. Fimmel, R.P. Walt, K. Harre, J. Röhmel, and L. Witzel Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls Gut 29 1988 1583 1587
79. P.L. Peghini, P.O. Katz, N.A. Bracy, and D.O. Castell Nocturnal recovery of gastric acid secretion with twice daily dosing of proton pump inhibitors Am J Gastroenterol 93 1998 763 767
80. N. Patel, U. Ward, M.J. Rogers, and J.N. Primrose Night-time or morning dosing with H2-receptor antagonists: studies on acid inhibition in normal subjects Aliment Pharmacol Ther 6 1992 381 387
81. V. Savarino, G.S. Mela, P. Zentilin, A. Sumberaz, P. Cutela, and G. Celle Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring Digestion 48 1991 141 148
82. S.W. Sanders, K.G. Tolman, P.A. Greski, D.E. Jennings, P.A. Hoyos, and J.G. Page The effects of lansoprazole, a new H +, K(+)-ATPase inhibitor, on gastric pH and serum gastrin Aliment Pharmacol Ther 6 1992 359 372
83. A.G. Fraser, A.M. Sawyer, M. Hudson, M.S. Smith, and R.E. Pounder Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects Aliment Pharmacol Ther 10 1996 523 527
84. S.G. Chiverton, C.W. Howden, D.W. Burget, and R.H. Hunt Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration Aliment Pharmacol Ther 6 1992 103 111
85. S. Müssig, L. Witzel, R. Lühmann, and A. Schneider Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH Eur J Gastroenterol Hepatol 9 1997 599 602
86. A.B. Thomson, P. Cohen, H. Ficheux, P. Fiorentini, F. Domagala, and M. Homerin Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study Aliment Pharmacol Ther 23 2006 1179 1187
87. M.H. Smolensky, A. Reinberg, and J.T. Queng The chronobiology and chronopharmacology of allergy Ann Allergy 47 1981 234 252
88. A. Reinberg, F. Halberg, and C.J. Falliers Circadian timing of methylprednisolone effects in asthmatic boys Chronobiologia 1 1974 333 347
89. W.R. Beam, D.E. Weiner, and R.J. Martin Timing of prednisone and alterations of airways inflammation in nocturnal asthma Am Rev Respir Dis 146 1992 1524 1530
90. D.J. Pincus, S.J. Szefler, L.M. Ackerson, and R.J. Martin Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy J Allergy Clin Immunol 95 1995 1172 1178
91. M. Gagnon, J. Côte, J. Milot, H. Turcotte, and L.P. Boulet Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma Chest 105 1994 1732 1737
92. J.P. Karpel, W.W. Busse, M.J. Noonan, M.E. Monahan, B. Lutsky, and H. Staudinger Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma Ann Pharmacother 39 2005 1977 1983
93. L. Thorsson, and A. Källén A randomized controlled assessment of the systemic activity of budesonide when given once or twice daily via Turbuhaler Eur J Clin Pharmacol 56 2000 207 210
94. P. Faurschou, A.M. Engel, and O.C. Haanaes Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies Allergy 49 1994 827 832
95. J.A. van Noord, J.J. Smeets, J.A.M. Raaijmakers, A.M. Bommer, and F.P.V. Maesen Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action Eur Respir J 9 1996 1684 1688
96. M. Masoli, M. Williams, M. Weatherall, and R. Beasley The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler Respir Med 100 2006 20 25
97. P.M. Calverley, A. Lee, L. Towse, J. van Noord, T.J. Witek, and S. Kelsen Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease Thorax 58 2003 855 860
98. L.C. Altman, Z. Munk, J. Seltzer, N. Noonan, S. Shingo, and J. Zhang A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group J Allergy Clin Immunol 102 1998 50 56
99. M. Pajaron-Fernandez, S. Garcia-Rubia, M. Sanchez-Solis, and L. Garcia-Marcos Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children Pediatr Pulmonol 41 2006 222 227